DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 44 · June 2011 DOI: 10.1055/s-002-22100

Original Paper

123
Ghio, L.; Natta, W.; Barbato, A.; Marcenaro, M.; Gotelli, S.; Jones, P. B.; Parabiaghi, A.: Schizophrenia Trial Participation: Perceived Inclusion Barriers and Beliefs about Antipsychotics
129
Sommer, M.; Braumann, M.; Althoff, T.; Backhaus, J.; Kordon, A.; Junghanns, K.; Ehrenthal, D.; Bartmann, U.; Hohagen, F.; Broocks, A.: Psychological and Neuroendocrine Responses to Social Stress and to the Administration of the alpha-2-Receptor Antagonist, Yohimbine, in Highly Trained Endurance Athletes in Comparison to Untrained Healthy Controls
135
Xiang, Y.-T.; Wang, C.-Y.; Ungvari, G. S.; Kreyenbuhl, J. A.; Chiu, H. F. K.; Lai, K. Y. C.; Lee, E. H. M.; Bo, Q.-J.; Dixon, L. B.: Weight Changes and their Associations with Demographic and Clinical Characteristics in Risperidone Maintenance Treatment for Schizophrenia
142
Molina, J. D.; Toledo-Romero, F.; López-Rodríguez, E.; Amorin-Díaz, M.; Lerma-Carrillo, I.; López-Muñoz, F.: Augmentation Treatment with Amisulpride in Schizophrenic Patients Partially Responsive to Olanzapine
148
Szulc, A.; Galinska, B.; Tarasow, E.; Waszkiewicz, N.; Konarzewska, B.; Poplawska, R.; Bibulowicz, D.; Simonienko, K.; Walecki, J.: Proton Magnetic Resonance Spectroscopy Study of Brain Metabolite Changes after Antipsychotic Treatment

Letter

158
Sánchez-Romero, A.; Mayordomo-Aranda, A.; García-Delgado, R.; Durán-Quintana, J. A.: Probable Interaction between Trazodone and Carbamazepine
159
Bachmann, H. S.; Lieb, B.; Bonnet, U.; Specka, M.; Augener, S.; Siffert, W.; Scherbaum, N.: Influence of the 393T>C Polymorphism of the GNAS1 Gene on the Intensity of Opiate Withdrawal
161
Eckert, G. P.; Schaeffer, E. L.; Schmitt, A.; Maras, A.; Gattaz, W. F.: Increased Brain Membrane Fluidity in Schizophrenia

Erratum

163
Koethe, D.; Bortolato, M.; Piomelli, D.; Leweke, F. M.: Improvement of General Symptoms in a Chronic Psychotic Patient Treated with Finasteride: Case Report